South Korea · Delayed Price · Currency is KRW ST Pharm Company Description
ST Pharm Co. Ltd., a contract development manufacturing organization, provides products for pharmaceutical and non-pharmaceutical area in South Korea.
The company offers chemistry manufacturing control (CMC) services, which includes analytical method development; in-house reference standard testing; analytical method qualification/validation; analytical characterization; and CMC documentation.
It also provides oligonucleotide based products, such as antisense, siRNA, miRNA, aptamer, CpG, decoy, and other products; and monomer/phosphoramidite.
In addition, the company offers generic APIs for anti-cancer, anti-coagulant, anti-fungal, anti-hyperlipidemia, anti-hypertensive, anti-tuberculosis, asthma, COPD, cough suppressant, diabetes mellitus, epilepsy, hepatitis B, and erectile dysfunction medicines, as well as MRI contrast agents.
Further, it provides 2nd battery, electronic materials, and polymer catalysts. The company was formerly known as Samchully Pharmaceutical Company., Ltd. ST Pharm Co. Ltd. was founded in 1983 and is based in Seoul, South Korea.
| Country | South Korea |
| Founded | 1983 |
| Industry | Medical - Pharmaceuticals |
| Sector | Healthcare |
| CEO | Mooje Sung |
Contact Details
Address: Sihwa Industrial Complex 1na 802 Siheung-si South Korea | |
| Phone | 82 3 1488 1300 |
Stock Details
| Ticker Symbol | 237690 |
| Exchange | KOSDAQ |
| Fiscal Year | January - December |
| Reporting Currency | KRW |
| ISIN Number | KR7237690003 |
| SIC Code | 2833 |
Key Executives
| Name | Position |
|---|---|
| Mooje Sung | Chief Executive Officer |
| Yonghoon Choi | Chief Financial Officer |